Cited by 127

MicroRNA-125b regulates microglia activation and motor neuron death in ALS

Parisi, C, Napoli, G, Amadio, S, Spalloni, A, Apolloni, S, Longone, P, Volonté, C·2016·Cell Death & Differentiation

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/cdd.2015.153

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 56

  1. Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 2014; 10: 661–670. 25311585
  2. Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 2014; 17: 17–23. 24369373 PMC4544832
  3. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994; 264: 1772–1775. 8209258
  4. Poppe L, Rue L, Robberecht W, Van Den Bosch L. Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS). Exp Neurol 2014; 262: 138–151. 25017368
  5. Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 2013; 14: 248–264. 23463272
  6. Paez-Colasante X, Figueroa-Romero C, Sakowski SA, Goutman SA, Feldman EL. Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nat Rev Neurol 2015; 11: 266–279. 25896087
  7. Philips T, Rothstein JD. Glial cells in amyotrophic lateral sclerosis. Exp Neurol 2014; 262: 111–120. 24859452 PMC4241182
  8. Brites D, Vaz AR. Microglia centered pathogenesis in ALS: insights in cell interconnectivity. Front Cell Neurosci 2014; 8: 117. 24904276 PMC4033073
  9. D'Ambrosi N, Rossi S, Gerbino V, Cozzolino M. Rac1 at the crossroad of actin dynamics and neuroinflammation in amyotrophic lateral sclerosis. Front Cell Neurosci 2014; 8: 279. 25249940 PMC4157560
  10. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell 2010; 140: 918–934. 20303880 PMC2873093
  11. Swarup V, Phaneuf D, Dupre N, Petri S, Strong M, Kriz J et al. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways. J Exp Med 2011; 208: 2429–2447. 22084410 PMC3256969
  12. Zhu G, Wu CJ, Zhao Y, Ashwell JD. Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. Curr Biol 2007; 17: 1438–1443. 17702576
  13. Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010; 465: 223–226. 20428114
  14. Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ et al. Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis. Neuron 2014; 81: 1009–1023. 24607225 PMC3978641
  15. Renner F, Schmitz ML. Autoregulatory feedback loops terminating the NF-kappaB response. Trends Biochem Sci 2009; 34: 128–135. 19233657
  16. Opipari AW Jr, Boguski MS, Dixit VM. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem 1990; 265: 14705–14708. 2118515
  17. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004; 430: 694–699. 15258597
  18. Vereecke L, Beyaert R, van Loo G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol 2009; 30: 383–391. 19643665
  19. Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 2004; 5: 1052–1060. 15334086
  20. Guedes RP, Csizmadia E, Moll HP, Ma A, Ferran C, da Silva CG. A20 deficiency causes spontaneous neuroinflammation in mice. J Neuroinflammation 2014; 11: 122. 25026958 PMC4128606
  21. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215–233. 19167326 PMC3794896
  22. Volonté C, Apolloni S, Parisi C. MicroRNAs: newcomers into the ALS picture. CNS Neurol Disord Drug Targets 2015; 14: 194–207. 25613506
  23. Morlando M, Dini Modigliani S, Torrelli G, Rosa A, Di Carlo V, Caffarelli E et al. FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J 2012; 31: 4502–4510. 23232809 PMC3545295
  24. Di Carlo V, Grossi E, Laneve P, Morlando M, Dini Modigliani S, Ballarino M et al. TDP-43 regulates the microprocessor complex activity during in vitro neuronal differentiation. Mol Neurobiol 2013; 48: 952–963. 24113842
  25. Ma X, Becker Buscaglia LE, Barker JR, Li Y. MicroRNAs in NF-kappaB signaling. J Mol Cell Biol 2011; 3: 159–166. 21502305 PMC3104013
  26. Kim SW, Ramasamy K, Bouamar H, Lin AP, Jiang D, Aguiar RC. MicroRNAs miR-125a and miR-125b constitutively activate the NF-kappaB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc Natl Acad Sci USA 2012; 109: 7865–7870. 22550173 PMC3356650
  27. Apolloni S, Parisi C, Pesaresi MG, Rossi S, Carri MT, Cozzolino M et al. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis. J Immunol 2013; 190: 5187–5195. 23589615
  28. D'Ambrosi N, Finocchi P, Apolloni S, Cozzolino M, Ferri A, Padovano V et al. The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis. J Immunol 2009; 183: 4648–4656. 19734218
  29. Apolloni S, Amadio S, Parisi C, Matteucci A, Potenza RL, Armida M et al. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis. Dis Model Mech 2014; 7: 1101–1109. 25038061 PMC4142730
  30. Parisi C, Arisi I, D'Ambrosi N, Storti AE, Brandi R, D'Onofrio M et al. Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation. Cell Death Dis 2013; 4: e959. 24336079 PMC3877562
  31. Liu B, Jiang D, Ou Y, Hu Z, Jiang J, Lei X. An anti-inflammatory role of A20 zinc finger protein during trauma combined with endotoxin challenge. J Surg Res 2013; 185: 717–725. 24055365
  32. Lai TY, Wu SD, Tsai MH, Chuang EY, Chuang LL, Hsu LC et al. Transcription of Tnfaip3 is regulated by NF-kappaB and p38 via C/EBPbeta in activated macrophages. PLoS One 2013; 8: e73153. 24023826 PMC3759409
  33. Austin JW, Gilchrist C, Fehlings MG. High molecular weight hyaluronan reduces lipopolysaccharide mediated microglial activation. J Neurochem 2012; 122: 344–355. 22587438
  34. Ferrari D, Wesselborg S, Bauer MK, Schulze-Osthoff K. Extracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively targeting NF-kappaB p65. J Cell Biol 1997; 139: 1635–1643. 9412459 PMC2132650
  35. Vande Walle L, Van Opdenbosch N, Jacques P, Fossoul A, Verheugen E, Vogel P et al. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature 2014; 512: 69–73. 25043000 PMC4126806
  36. Collart MA, Baeuerle P, Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 1990; 10: 1498–1506. 2181276 PMC362253
  37. Hide I, Tanaka M, Inoue A, Nakajima K, Kohsaka S, Inoue K et al. Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J Neurochem 2000; 75: 965–972. 10936177
  38. Lim H, Kim D, Lee SJ. Toll-like receptor 2 mediates peripheral nerve injury-induced NADPH oxidase 2 expression in spinal cord microglia. J Biol Chem 2013; 288: 7572–7579. 23386616 PMC3597798
  39. Leto TL, Morand S, Hurt D, Ueyama T. Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid Redox Signal 2009; 11: 2607–2619. 19438290 PMC2782575
  40. Mancuso R, Navarro X. Amyotrophic lateral sclerosis: current perspectives from basic research to the clinic. Prog Neurobiol 2015; 133: 1–26. 26253783
  41. Valori CF, Brambilla L, Martorana F, Rossi D. The multifaceted role of glial cells in amyotrophic lateral sclerosis. Cell Mol Life Sci 2014; 71: 287–297. 23912896 PMC11113174
  42. Endo F, Komine O, Fujimori-Tonou N, Katsuno M, Jin S, Watanabe S et al. Astrocyte-derived TGF-beta1 accelerates disease progression in ALS mice by interfering with the neuroprotective functions of microglia and T cells. Cell Rep 2015; 11: 592–604. 25892237
  43. Zhao W, Beers DR, Appel SH. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol 2013; 8: 888–899. 23881705 PMC4126425
  44. Volonté C, Apolloni S, Skaper SD, Burnstock G. P2X7 receptors: channels, pores and more. CNS Neurol Disord Drug Targets 2012; 11: 705–721. 22963440
  45. Volonté C, Apolloni S, Carri MT, D'Ambrosi N. ALS: focus on purinergic signalling. Pharmacol Ther 2011; 132: 111–122. 21704075
  46. Butovsky O, Jedrychowski MP, Cialic R, Krasemann S, Murugaiyan G, Fanek Z et al. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol 2015; 77: 75–99. 25381879 PMC4432483
  47. Aga M, Watters JJ, Pfeiffer ZA, Wiepz GJ, Sommer JA, Bertics PJ. Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-kappa B signaling pathways in murine RAW 264.7 macrophages. Am J Physiol Cell Physiol 2004; 286: C923–C930. 14684387
  48. Zhao Y, Bhattacharjee S, Jones BM, Hill J, Dua P, Lukiw WJ. Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells. Mol Neurobiol 2014; 50: 97–106. 24293102 PMC4038663
  49. Colton CA. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009; 4: 399–418. 19655259 PMC2773116
  50. Ivashkiv LB. Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Eur J Immunol 2008; 41: 2477–2481. PMC3264328 21952800
  51. Beers DR, Zhao W, Liao B, Kano O, Wang J, Huang A et al. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain Behav Immun 2011; 25: 1025–1035. 21176785 PMC3096756
  52. Valente T, Mancera P, Tusell JM, Serratosa J, Saura J. C/EBPbeta expression in activated microglia in amyotrophic lateral sclerosis. Neurobiol Aging 2012; 33: 2186–2199. 22015310
  53. Catrysse L, Vereecke L, Beyaert R, van Loo G. A20 in inflammation and autoimmunity. Trends Immunol 2014; 35: 22–31. 24246475
  54. Coornaert B, Carpentier I, Beyaert R. A20: central gatekeeper in inflammation and immunity. J Biol Chem 2009; 284: 8217–8221. 19008218 PMC2659177
  55. Turer EE, Tavares RM, Mortier E, Hitotsumatsu O, Advincula R, Lee B et al. Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20. J Exp Med 2008; 205: 451–464. 18268035 PMC2271029
  56. Spalloni A, Albo F, Ferrari F, Mercuri N, Bernardi G, Zona C et al. Cu/Zn-superoxide dismutase (GLY93—>ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture. Neurobiol Dis 2004; 15: 340–350. 15006704

Cited by

Sorted by citations

Authors
Parisi, C., Napoli, G., Amadio, S., Spalloni, A., Apolloni, S., Longone, P., & Volonté, C.
Venue
Cell Death & Differentiation
Published
2016-01-22
Volume
23
Issue
3
Pages
531-541
ISSN
  • 1350-9047
  • 1476-5403
Cited by
127
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review